StockData
Elevance Health, Inc. logo

Elevance Health, Inc. (ELV) operating KPIs

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3012% below fair value
$420.07−1.95 (-0.46%)

Close on Oct 30, 2026Market cap $91.10BP/E 18.7Yield –

Elevance Health income Before Income Tax Expense (GAAP Pretax Income) ($M)

Quarterly figures from Elevance Health's filings and investor materials

QuarterlyAnnual
Latest, Q3 2026
1,794
Period ended Sep 30, 2026
Change on a year earlier
+27.6%
1,406 in Q3 2025
History
47 quarters
Since Q1 2015
Sources
3
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedIncome Before Income Tax Expense (GAAP Pretax Income) ($M)Year on yearSource
Q3 2026Sep 30, 20261,794+27.6%ELV 10-Q (XBRL us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest) ↗
Q2 2026Jun 30, 20261,937-15.5%ELV 10-Q (XBRL us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest) ↗
Q1 2026Mar 31, 20262,304-17.6%ELV 10-Q (XBRL us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest) ↗
Q4 2025Dec 31, 2025215-64.5%ELV 10-K (XBRL us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest) ↗
Q3 2025Sep 30, 20251,406+2.4%ELV 10-Q (XBRL us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest) ↗
Q2 2025Jun 30, 20252,292-23.2%ELV 10-Q (XBRL us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest) ↗
Q1 2025Mar 31, 20252,797-4.8%ELV 10-Q (XBRL us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest) ↗
Q4 2024Dec 31, 2024606-39.5%ELV 10-K (XBRL us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest) ↗
Q3 2024Sep 30, 20241,373-17.0%ELV 10-Q (XBRL us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest) ↗
Q2 2024Jun 30, 20242,986+22.3%ELV 10-Q (XBRL us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest) ↗
Q1 2024Mar 31, 20242,939+12.2%ELV 10-Q (XBRL us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest) ↗
Q4 2023Dec 31, 20231,001-4.2%ELV 10-K (XBRL us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest) ↗
Q3 2023Sep 30, 20231,654-22.2%ELV 10-Q (XBRL us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest) ↗
Q2 2023Jun 30, 20232,441+15.0%ELV 10-Q (XBRL us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest) ↗
Q1 2023Mar 31, 20232,619+13.6%ELV 10-Q (XBRL us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest) ↗
Q4 2022Dec 31, 20221,045-28.9%ELV 10-K (XBRL us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest) ↗

Cite this data

StockData. (2026). Elevance Health Income Before Income Tax Expense (GAAP Pretax Income) ($M), quarterly Q1 2015–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/fin_pretax_income

See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.